EX-23.2 5 a202310-kexhibit232.htm EX-23.2

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements (Nos. 333-262403 and 333-262404) on Form S-3 and (Nos. 333-263466, 333-270357 and 333-260068) on Form S-8 of our report dated March 8, 2023, with respect to the consolidated financial statements of Xeris Biopharma Holdings, Inc.

/s/ KPMG LLP

Chicago, Illinois

March 6, 2024